| Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 T Sekine, A Perez-Potti, O Rivera-Ballesteros, K Strålin, JB Gorin, ... Cell 183 (1), 158-168. e14, 2020 | 1960 | 2020 |
| Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation M von Köckritz-Blickwede, O Goldmann, P Thulin, K Heinemann, ... Blood, The Journal of the American Society of Hematology 111 (6), 3070-3080, 2008 | 688 | 2008 |
| Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial J Darenberg, N Ihendyane, J Sjölin, E Aufwerber, S Haidl, P Follin, ... Clinical infectious diseases 37 (3), 333-340, 2003 | 655 | 2003 |
| Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome—a comparative observational study R Kaul, A McGeer, A Norrby-Teglund, M Kotb, B Schwartz, K O'Rourke, ... Clinical infectious diseases 28 (4), 800-807, 1999 | 641 | 1999 |
| Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock J Sundén-Cullberg, A Norrby-Teglund, A Rouhiainen, H Rauvala, ... Critical care medicine 33 (3), 564-573, 2005 | 562 | 2005 |
| An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections M Kotb, A Norrby-Teglund, A McGeer, H El-Sherbini, MT Dorak, ... Nature medicine 8 (12), 1398-1404, 2002 | 458 | 2002 |
| M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage H Herwald, H Cramer, M Mörgelin, W Russell, U Sollenberg, ... Cell 116 (3), 367-379, 2004 | 405 | 2004 |
| Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases S Chatellier, N Ihendyane, RG Kansal, F Khambaty, H Basma, ... Infection and immunity 68 (6), 3523-3534, 2000 | 303 | 2000 |
| Neutrophils acquire the capacity for antigen presentation to memory CD4+ T cells in vitro and ex vivo M Vono, A Lin, A Norrby-Teglund, RA Koup, F Liang, K Loré Blood, The Journal of the American Society of Hematology 129 (14), 1991-2001, 2017 | 294 | 2017 |
| Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden J Darenberg, B Luca-Harari, A Jasir, A Sandgren, H Pettersson, ... Clinical infectious diseases 45 (4), 450-458, 2007 | 241 | 2007 |
| Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study A Linnér, J Darenberg, J Sjölin, B Henriques-Normark, A Norrby-Teglund Clinical Infectious Diseases 59 (6), 851-857, 2014 | 233 | 2014 |
| Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation … A Norrby-Teglund, R Kaul, DE Low, A McGeer, DW Newton, J Andersson, ... Journal of immunology (Baltimore, Md.: 1950) 156 (8), 3057-3064, 1996 | 224 | 1996 |
| Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal … RG Kansal, A McGeer, DE Low, A Norrby-Teglund, M Kotb Infection and immunity 68 (11), 6362-6369, 2000 | 221 | 2000 |
| Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense TG Loof, M Mörgelin, L Johansson, S Oehmcke, AI Olin, G Dickneite, ... Blood, The Journal of the American Society of Hematology 118 (9), 2589-2598, 2011 | 216 | 2011 |
| Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with … A Norrby-Teglund, MP Muller, A McGeer, BS Gan, V Guru, J Bohnen, ... Scandinavian journal of infectious diseases 37 (3), 166-172, 2005 | 213 | 2005 |
| Streptococcal M protein: a multipotent and powerful inducer of inflammation LI Påhlman, M Mörgelin, J Eckert, L Johansson, W Russell, ... The Journal of Immunology 177 (2), 1221-1228, 2006 | 200 | 2006 |
| Invasive group B Streptococcal disease in non-pregnant adults: a review with emphasis on skin and soft-tissue infections P Sendi, L Johansson, A Norrby-Teglund Infection 36 (2), 100-111, 2008 | 197 | 2008 |
| Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor EJ Giamarellos-Bourboulis, A Norrby-Teglund, V Mylona, A Savva, ... Critical care 16, 1-10, 2012 | 189 | 2012 |
| MAIT cell activation and dynamics associated with COVID-19 disease severity T Parrot, JB Gorin, A Ponzetta, KT Maleki, T Kammann, J Emgård, ... Science immunology 5 (51), eabe1670, 2020 | 188 | 2020 |
| Viable group A streptococci in macrophages during acute soft tissue infection P Thulin, L Johansson, DE Low, BS Gan, M Kotb, A McGeer, ... PLoS medicine 3 (3), e53, 2006 | 186 | 2006 |
